Systemic sclerosis & Raynaud's

High levels of vascular cell adhesion molecule-1 associate with a ‘vasculopathic’ phenotype in systemic sclerosis with higher mortality

Rheumatology (Oxford)Published Cohort study

Main finding · MortalityResult — go to the resultHazard ratio 2.17 95% CI 1.54–3.04

Authors' conclusion

The increased mortality in participants with SSc and Q4 VCAM-1 levels is attributable to increased frequency of vascular disease manifestations.

Study context

Population
Participants with SSc from the Australian Scleroderma Cohort Study87.1% female
Participants
388 participants
Exposure
Upper quartile serum VCAM-1 vs other quartiles
Outcome
Mortality
Methodological detailslinked with the National Death Index, stratified into VCAM-1 quartiles
  • Linked with the National Death Index
  • Stratified into VCAM-1 quartiles

Main finding

As reported in the abstract

Hazard ratio

2.17

95% CI 1.54–3.04

P < 0.001

Q4vs Others
HR 2.17 (95% CI 1.54–3.04); P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Cause-specific mortality (listed as cause or contributor to death)Q4vs OthersPAH3.08 (1.68–5.65)P < 0.001
Cause-specific mortality (listed as cause or contributor to death)Q4vs OthersSSc-attributable myocardial disease2.85 (1.51–5.38)P = 0.001
Cause-specific mortality (listed as cause or contributor to death)Q4vs OthersAll-cause CVD2.50 (1.60–3.89)P < 0.001

Organ manifestations across VCAM-1 quartiles

Q4 more likely to have pulmonary arterial hypertension (PAH)
P = 0.028
Q4 more likely to have SSc-attributable myocardial disease
P = 0.009
Q4 more likely to have digital ulcers
P = 0.003
No statistically significant differences in sex, age, disease duration, disease subtype, autoantibody profile or FVC across quartiles
Q4 not associated with ILD presence, severity or cause-specific mortality

Original publication

High levels of vascular cell adhesion molecule-1 associate with a ‘vasculopathic’ phenotype in systemic sclerosis with higher mortality. Rheumatology (Oxford). Published 29 July 2026. doi:10.1093/rheumatology/keag391

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.